Literature DB >> 9224629

Importance of aspartate-70 in organophosphate inhibition, oxime re-activation and aging of human butyrylcholinesterase.

P Masson1, M T Froment, C F Bartels, O Lockridge.   

Abstract

Asp-70 is the defining amino acid in the peripheral anionic site of human butyrylcholinesterase (BuChE), whereas acetylcholinesterase has several additional amino acids, the most important one being Trp-277 (Trp-279 in Torpedo AChE). We studied mutants D70G, D70K and A277W to evaluate the role of Asp-70 and Trp-277 in reactions with organophosphates. We found that Asp-70 was important for binding positively charged echothiophate, but not neutral paraoxon and iso-OMPA. Asp-70 was also important for binding of positively charged pralidoxime (2-PAM) and for activation of re-activation by excess 2-PAM. Excess 2-PAM had an effect similar to substrate activation, suggesting the binding of 2 mol of 2-PAM to wild-type but not to the D70G mutant. A surprising result was that Asp-70 was important for irreversible aging, the D70G mutant having a 3- and 8-fold lower rate of aging for paraoxon-inhibited and di-isopropyl fluorophosphate-inhibited BuChE. Mutants of Asp-70 had the same rate constants for phosphorylation and re-activation by 2-PAM as wild-type. The A277W mutant behaved like wild-type in all assays. Our results predict that people with the atypical (D70G) variant of BuChE will be more sensitive to the toxic effects of echothiophate, but will be equally sensitive to paraoxon and di-isopropyl fluorophosphate. People with the D70G mutation will be resistant to re-activation of their inhibited BuChE by 2-PAM, but this will be offset by the lower rate of irreversible aging of inhibited BuChE, allowing some regeneration by spontaneous hydrolysis.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9224629      PMCID: PMC1218528          DOI: 10.1042/bj3250053

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  45 in total

1.  Differences in conformational stability between native and phosphorylated acetylcholinesterase as evidenced by a monoclonal antibody.

Authors:  Y Ashani; M K Gentry; B P Doctor
Journal:  Biochemistry       Date:  1990-03-13       Impact factor: 3.162

2.  Chiral reactions of acetylcholinesterase probed with enantiomeric methylphosphonothioates. Noncovalent determinants of enzyme chirality.

Authors:  H A Berman; K Leonard
Journal:  J Biol Chem       Date:  1989-03-05       Impact factor: 5.157

3.  In vitro studies on the reactivation by oximes of phosphylated acetylcholinesterase--I. On the reactions of P2S with various organophosphates and the properties of the resultant phosphylated oximes.

Authors:  B Harvey; R P Scott; D J Sellers; P Watts
Journal:  Biochem Pharmacol       Date:  1986-03-01       Impact factor: 5.858

4.  Engineering resistance to 'aging' of phosphylated human acetylcholinesterase. Role of hydrogen bond network in the active center.

Authors:  A Ordentlich; C Kronman; D Barak; D Stein; N Ariel; D Marcus; B Velan; A Shafferman
Journal:  FEBS Lett       Date:  1993-11-15       Impact factor: 4.124

5.  A simple graphical method for determining the inhibition constants of mixed, uncompetitive and non-competitive inhibitors.

Authors:  A Cornish-Bowden
Journal:  Biochem J       Date:  1974-01       Impact factor: 3.857

6.  Recombinant human butyrylcholinesterase G390V, the fluoride-2 variant, expressed in Chinese hamster ovary cells, is a low affinity variant.

Authors:  P Masson; S Adkins; P Gouet; O Lockridge
Journal:  J Biol Chem       Date:  1993-07-05       Impact factor: 5.157

7.  Horse serum butyrylcholinesterase kinetics: a molecular mechanism based on inhibition studies with dansylaminoethyltrimethylammonium.

Authors:  G Cauet; A Friboulet; D Thomas
Journal:  Biochem Cell Biol       Date:  1987-06       Impact factor: 3.626

8.  In vitro reactivation and "ageing" of Tabuninhibited blood cholinesterases; studies with N-methyl-pyridinium-2-aldoxime methane sulphonate and N,N'-trimethylene bis (pyridinium-4-aldoxime) dibromide.

Authors:  E HEILBRONN
Journal:  Biochem Pharmacol       Date:  1963-01       Impact factor: 5.858

9.  The role of glutamate-199 in the aging of cholinesterase.

Authors:  A Saxena; B P Doctor; D M Maxwell; D E Lenz; Z Radic; P Taylor
Journal:  Biochem Biophys Res Commun       Date:  1993-11-30       Impact factor: 3.575

10.  Kinetics of butyrylcholinesterase in reversed micelles under high pressure.

Authors:  C Clery; N Bec; C Balny; V V Mozhaev; P Masson
Journal:  Biochim Biophys Acta       Date:  1995-11-15
View more
  18 in total

1.  Direct quantitation of methyl phosphonate adducts to human serum butyrylcholinesterase by immunomagnetic-UHPLC-MS/MS.

Authors:  Melissa D Carter; Brian S Crow; Brooke G Pantazides; Caroline M Watson; Jerry D Thomas; Thomas A Blake; Rudolph C Johnson
Journal:  Anal Chem       Date:  2013-11-08       Impact factor: 6.986

2.  His-tag truncated butyrylcholinesterase as a useful construct for in vitro characterization of wild-type and variant butyrylcholinesterases.

Authors:  Erik C Ralph; Longkuan Xiang; John R Cashman; Jun Zhang
Journal:  Protein Expr Purif       Date:  2011-07-23       Impact factor: 1.650

3.  Characterization of butyrylcholinesterase in bovine serum.

Authors:  Alicia J Dafferner; Sofya Lushchekina; Patrick Masson; Gaoping Xiao; Lawrence M Schopfer; Oksana Lockridge
Journal:  Chem Biol Interact       Date:  2017-02-08       Impact factor: 5.192

4.  Resolving pathways of interaction of mipafox and a sarin analog with human acetylcholinesterase by kinetics, mass spectrometry and molecular modeling approaches.

Authors:  I Mangas; P Taylor; E Vilanova; J Estévez; T C C França; E Komives; Z Radić
Journal:  Arch Toxicol       Date:  2015-03-06       Impact factor: 5.153

5.  Detection of adduct on tyrosine 411 of albumin in humans poisoned by dichlorvos.

Authors:  Bin Li; Ivan Ricordel; Lawrence M Schopfer; Frédéric Baud; Bruno Mégarbane; Florian Nachon; Patrick Masson; Oksana Lockridge
Journal:  Toxicol Sci       Date:  2010-04-15       Impact factor: 4.849

Review 6.  Resurrection and Reactivation of Acetylcholinesterase and Butyrylcholinesterase.

Authors:  Andrew J Franjesevic; Sydney B Sillart; Jeremy M Beck; Shubham Vyas; Christopher S Callam; Christopher M Hadad
Journal:  Chemistry       Date:  2019-02-13       Impact factor: 5.236

7.  Aging of di-isopropyl-phosphorylated human butyrylcholinesterase.

Authors:  P Masson; P L Fortier; C Albaret; M T Froment; C F Bartels; O Lockridge
Journal:  Biochem J       Date:  1997-10-15       Impact factor: 3.857

Review 8.  Butyrylcholinesterase for protection from organophosphorus poisons: catalytic complexities and hysteretic behavior.

Authors:  Patrick Masson; Oksana Lockridge
Journal:  Arch Biochem Biophys       Date:  2009-12-11       Impact factor: 4.013

9.  Chemical synthesis of two series of nerve agent model compounds and their stereoselective interaction with human acetylcholinesterase and human butyrylcholinesterase.

Authors:  Nora H Barakat; Xueying Zheng; Cynthia B Gilley; Mary MacDonald; Karl Okolotowicz; John R Cashman; Shubham Vyas; Jeremy M Beck; Christopher M Hadad; Jun Zhang
Journal:  Chem Res Toxicol       Date:  2009-10       Impact factor: 3.739

10.  Nerve agent analogues that produce authentic soman, sarin, tabun, and cyclohexyl methylphosphonate-modified human butyrylcholinesterase.

Authors:  Cynthia Gilley; Mary MacDonald; Florian Nachon; Lawrence M Schopfer; Jun Zhang; John R Cashman; Oksana Lockridge
Journal:  Chem Res Toxicol       Date:  2009-10       Impact factor: 3.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.